The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 2, 1998, Pages 321-327

  Mason, K ^a   Heal, D J ^b   Stanford, S C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

FG 7142; Microdialysis; Noradrenaline; Novel environment; Stress; Yohimbine

Indexed keywords

N METHYL BETA CARBOLINE 3 CARBOXAMIDE; YOHIMBINE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CALCULATION; DOSE RESPONSE; FRONTAL CORTEX; LOCOMOTION; MICRODIALYSIS; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANXIETY; BRAIN CHEMISTRY; CARBOLINES; ENVIRONMENT; GABA ANTAGONISTS; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; YOHIMBINE;

EID: 0032101087     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00564-9     Document Type: Article

References (31)

1. Abercrombie E.D., Keller R.W., Zigmond M. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion. Pharmacological and behavioral studies J. Neurosci. 27:1988;897-904.
2. Bassareo V., Tanda G., Petromilli P., Giua C., Di Chiara G. Nonpsychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology (Berlin). 1124:1996;293-299.
3. Bradberry C.M., Lory J.D., Roth R.H. The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in the rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56:1991;748-752.
4. Charney D.S., Heninger G.R., Redmond D.E. Yohimbine induced anxiety and increased noradrenergic function in humans. Effects of diazepam and clonidine Life Sci. 33:1983;19-29.
5. Cole B.J., Hillman M., Seidelmann D., Klewer M., Jones G.H. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat. Psychopharmacology (Berlin). 121:1995;118-126.
6. Dalley J.W., Stanford S.C. Incremental changes in extracellular noradrenaline availability in the frontal cortex induced by naturalistic environmental stimuli. A microdialysis study in the freely moving rat J. Neurochem. 65:1995;2644-2651.
7. Dalley J.W., Mason K., Stanford S.C. Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli. Modulation by acute systemic administration of diazepam or buspirone Psychopharmacology (Berlin). 127:1996;47-54.
8. Delini-Stula A., Hunn C. Differential effects of anxiolytics and β-receptor blocking drugs on novelty-oriented ('neophobic') behavior in the rat. Pharmacopsychiatry. 21:1988;186-191.
9. Dorow, R.; Horowski, R.; Paschelke, G.; Amin, M.: Severe anxiety induced by FG7142, a β-carboline ligand for benzodiazepine receptors. Lancet ii:98-99; 1983.
10. File S.E., Pellow S., Braestrup C. Effects of the β-carboline, FG 7142, in the social interaction test of anxiety and the holeboard. Correlations between behaviour and plasma concentrations Pharmacol. Biochem. Behav. 22:1985;941-944.
11. 2-Adrenoceptor antagonists activity may account for the effects of buspirone in an anticonflict test in the rat. Eur. J. Pharmacol. 155:1988;128-137.
12. Graeff F.G., Guimaraes F.S., De Andrade T.G.C.S., Deakin J.F.W. Role of 5-HT in stress, anxiety and depression. Pharmacol. Biochem. Behav. 54:1996;129-141.
13. Guy A.P., Gardner C.R. Pharmacological characterization of a modified social interaction model of anxiety in the rat. Neuropsychobiology. 13:1985;194-200.
14. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 327:1984;1-5.
15. Itoh Y., Oishi R., Nishibori M., Saeki K. In vivo measurement of noradrenaline and 3,4,dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis. Effects of various drugs affecting noradrenaline metabolism J. Pharmacol. Exp. Ther. 255:1990;1090-1097.
16. Johnston A.L., File S.E. Yohimbine's anxiogenic action. Evidence for noradrenergic and dopaminergic sites Pharmacol. Biochem. Behav. 32:1989;151-156.
17. La Marca S., Dunn R.W. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration. Life Sci. 54:1994;PL179-PL184.
18. Nakane H., Shimizu N., Hori T. Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am. J. Physiol. 267:1994;R1559-R1566.
19. Paxinos, G.; Watson, C.: The rat brain in sterotaxic coordinates. 2nd ed. London: Academic Press Inc; 1986.
20. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze. A novel test of anxiety in the rat Pharmacol. Biochem. Behav. 24:1986;525-529.
21. Pellow S., Chopin P., File S.E. Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors? Neurosci. Lett. 55:1985;5-9.
22. 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. Br. J. Pharmacol. 116:1995;2081-2089.
23. Redmond D.E., Huang Y.H. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci. 25:1979;2149-2162.
24. Söderpalm A., Blomqvist O., Söderpalm B. The yohimbine-induced anticonflict effect in the rat, part 1. Involvement of noradrenergic serotonergic and endozepinergic (?) mechanisms. J. Neural Transm. 100:1995;175-189.
25. Southwick S.M., Krystal J.H., Morgan C.A., Johnson D., Nagy L.M., Nicolaou A., Heninger G.R., Charney D.S. Abnormal noradrenergic function in post-traumatic stress disorder. Arch. Gen. Psychiatry. 50:1993;266-274.
26. Stanford S.C., Baldwin H.A., File S.E. Effects of a single or repeated administration of the benzodiazepine inverse agonist, FG7142 on behaviour and cortical adrenoceptor binding in rat. Psychopharmacology (Berlin). 98:1989;417-424.
27. Stanford S.C., Gettins D., Baldwin H.A. Non-noxious stress and the benzodiazepine inverse agonist, FG7142, have opposing effects on noradrenaline release in rat frontal cortex. Br. J. Pharmacol. 107:1992;350P.
28. Tanda G., Bassareo V., Di Chiara G. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berlin). 123:1996;127-130.
29. Vahabzadeh A., Fillenz M. Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis. Eur. J. Neurosci. 6:1994;1205-1212.
30. Venault P., Jacquot F., Save E., Sara S., Chapouthier G. Anxiogenic-like effects of yohimbine and idazoxan in two behavioural situations in mice. Life Sci. 52:1993;639-645.
31. Yokoo H., Tanaka M., Yoshida M., Tsuda A., Tanaka T., Mizoguchi K. Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis. Brain Res. 536:1990;305-308.